Rice bran extract compensates mitochondrial dysfunction in a cellular model of early Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 43, Issue 3, 2015, Pages 927-938

  Hagl, Stephanie ^a   Grewal, Rekha ^a   Ciobanu, Ion ^a   Helal, Amr ^b   Khayyal, Mohamed T ^c   Muller, Walter E ^a   Eckert, Gunter P ^a  

^a GOETHE UNIVERSITY   (Germany)

^b ITandM   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Alzheimer's disease; bioenergetics; mitochondria; mitochondrial dynamics; nitrosative stress; nutrition; PC12 cells; respiration; rice bran extract

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOTRIENOL; AMYLOID BETA PROTEIN; CITRATE SYNTHASE; GAMMA ORYZANOL; MITOFUSIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR 1 ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLANT EXTRACT; RICE BRAN EXTRACT; TOCOPHEROL; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BREATHING RATE; CELL DAMAGE; CELL FUNCTION; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; MICROSCOPE; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RESPIRATION CONTROL; RICE BRAN; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; MITOCHONDRION; ORYZA; OXIDATIVE STRESS; PC12 CELL LINE; RAT; RICE;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; ANIMALS; CELL LINE; CITRATE (SI)-SYNTHASE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; ORYZA; ORYZA SATIVA; OXIDATIVE STRESS; PC12 CELLS; PLANT EXTRACTS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84914694983     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132084     Document Type: Article

References (50)

1. Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19, 53-77.
2. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
3. Blennow K, Leon MJ de, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403.
4. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535.
5. Caselli RJ, Beach TG, Yaari R, Reiman EM (2006) Alzheimer's disease a century later. J Clin Psychiatry 67, 1784-1800.
6. Morris JC, Cummings J (2005) Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis 7, 235-259; discussion 255-262.
7. Mangialasche F, Solomon A,Winblad B, Mecocci P, Kivipelto M(2010) Alzheimer's disease: Clinical trials and drug development. Lancet Neurol 9, 702-716.
8. Lukiw WJ (2012) Amyloid beta (Abeta) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin Emerg Drugs 17, 43-60.
9. Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44, 46-50.
10. Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE (2012) Mitochondrial dysfunction-a pharmacological target in Alzheimer's disease. Mol Neurobiol 46, 136-150.
11. MüllerW, Eckert A,Kurz C, Eckert G, LeunerK(2010) Mitochondrial dysfunction: Common final pathway in brain aging and Alzheimer's disease-therapeutic aspects. Mol Neurobiol 41, 159-171.
12. Young-Collier KJ, McArdle M, Bennett JP (2012) The dying of the light: Mitochondrial failure in Alzheimer's disease. J Alzheimers Dis 28, 771-781.
13. Pagani L, Eckert A (2011) Amyloid-beta interaction with mitochondria. Int J Alzheimers Dis 2011, 1-12.
14. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I,Keil U, Strosznajder JB, Eckert A, Muller WE (2007) Mitochondrial dysfunction: The first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal 9, 1659-1675.
15. Leuner K, Schutt T,Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Drose S,Wittig I,Willem M, Haass C, Reichert AS, Muller WE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16, 1421-1433.
16. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age inADtransgenic mice. Neurobiol Aging 30, 1574-1586.
17. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, Muller WE (2003) Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 66, 1627-1634.
18. Eckert SH, Eckmann J, Renner-Sattler K, Eckert GP, Leuner K, Mueller WE (2012) Dimebon ameliorates amyloid-beta induced impairments of mitochondrial form and function. J Alzheimers Dis 31, 21-32.
19. Schaffer S, Asseburg H, Kuntz S, Muller WE, Eckert GP (2012) Effects of polyphenols on brain ageing and Alzheimer's disease: Focus on mitochondria. Mol Neurobiol 46, 161-178.
20. Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D'Onofrio G, Addante F, Sancarlo D, Cascavilla L, Pilotto A, Panza F (2011) Mediterranean diet in predementia and dementia syndromes. Curr Alzheimer Res 8, 520-542.
21. Ramesh BN, Rao TSS, Prakasam A, Sambamurti K, Rao KSJ (2010) Neuronutrition and Alzheimer's disease. J Alzheimers Dis 19, 1123-1139.
22. Eckert GP, Lipka U, Muller WE (2013) Omega-3 fatty acids in neurodegenerative diseases: Focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids 88, 105-114.
23. Laokuldilok T, Shoemaker CF, Jongkaewwattana S, Tulyathan V (2011) Antioxidants and antioxidant activity of several pigmented rice brans. J Agric Food Chem 59, 193-199.
24. Hagl S,Kocher A, Schiborr C, Eckert SH, Ciobanu I, Birringer M, El-Askary H, Helal A, Khayyal MT, Frank J, Muller WE, Eckert GP (2013) Rice bran extract protects from mitochondrial dysfunction in guinea pig brains. Pharmacol Res 76, 17-27.
25. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73, 2424-2428.
26. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59-74.
27. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C, Muller WE (2001) Elevated vulnerability to oxidative stressinduced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 64, 183-192.
28. Yamamoto A, BehlC(2001) Human Nck-associated protein 1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation. Neurosci Lett 316, 50-54.
29. Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E (2006) Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1beta-treated human peritoneal mesothelial cells. Cell Biochem Biophys 44, 179-186.
30. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, Gnaiger E (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380, 919-928.
31. Kuznetsov AV, Strobl D, Ruttmann E, Königsrainer A, Margreiter R, Gnaiger E (2002) Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem 305, 186-194.
32. BrandMD,NichollsDG(2011) Assessing mitochondrial dysfunction in cells. Biochem J 435, 297-312.
33. Larsen S, Nielsen J, Hansen CN, Nielsen LB, Wibrand F, Stride N, Schroder HD, Boushel R, Helge JW, Dela F, Hey-Mogensen M (2012) Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects. J Physiol 590, 3349-3360.
34. Rabøl R, Larsen S, Højberg PMV, Almdal T, Boushel R, Haugaard SB, Andersen JL, Madsbad S, Dela F (2010) Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity. J Clin Endocrinol Metab 95, 857-863.
35. Hutter E, Unterluggauer H, Garedew A, Jansen-Durr P, Gnaiger E (2006) High-resolution respirometry-a modern tool in aging research. Exp Gerontol 41, 103-109.
36. Gnaiger E (2001) Bioenergetics at low oxygen: Dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. Respir Physiol 128, 277-297.
37. Fernandez-Marcos PJ, Auwerx J (2011) Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93, 884S-890S.
38. Strosznajder JB, Cieslik M, Cakala M, Jesko H, Eckert A, Strosznajder RP (2011) Lipoxygenases and poly(ADPribose) polymerase in amyloid beta cytotoxicity. Neurochem Res 36, 839-848.
39. Eckert A, Marques CA, Keil U, Schussel K, Muller WE (2003) Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann N Y Acad Sci 1010, 604-609.
40. Keil U, Bonert A, Marques CA, Strosznajder JB, Muller-Spahn F, Muller WE, Eckert A (2004) Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure. Pol J Pharmacol 56, 631-634.
41. López-Lluch G, Irusta PM, Navas P, Cabo R de (2008) Mitochondrial biogenesis and healthy aging. Exp Gerontol 43, 813-819.
42. Sheng B, Wang X, Su B, Lee H, Casadesus G, Perry G, Zhu X (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 120, 419-429.
43. Santos RX, Correia SC,Wang X, Perry G, Smith MA, Moreira PI, Zhu X (2010) A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis 20(Suppl 2), S401-S412.
44. Youle RJ, van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337, 1062-1065.
45. Austin S, St-Pierre J (2012) PGC1alpha and mitochondrial metabolism-emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125, 4963-4971.
46. Kapogiannis D, Mattson MP (2011) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 10, 187-198.
47. Hoyer S (2000) Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: An update. Exp Gerontol 35, 1363-1372.
48. Abramov AY, Canevari L, Duchen MR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24, 565-575.
49. MurphyMP (2009) How mitochondria produce reactive oxygen species. Biochem J 417, 1-13.
50. Manczak M, Reddy PH (2012) Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease. Hum Mol Genet 21, 5131-5146.